What is fdg pet

FDG PET Imaging Technology

FDG PET is one of the most sophisticated medical imaging techniques available today. It combines nuclear medicine with advanced imaging technology to create detailed pictures of how the body is functioning at a cellular level. The acronym stands for Fluorodeoxyglucose Positron Emission Tomography, and understanding what each component means helps explain how this powerful diagnostic tool works.

How FDG PET Works

The imaging process begins with the injection of FDG, a radioactive tracer that behaves like glucose in the body. Because cancer cells and certain other abnormal tissues typically consume glucose at higher rates than normal cells, they accumulate more of the tracer. The PET scanner detects the radiation emitted by the tracer and creates detailed images showing areas of high cellular activity. This allows doctors to identify tumors, areas of inflammation, and regions of disease that might not be visible on conventional imaging.

Cancer Detection and Monitoring

FDG PET is particularly valuable in oncology, where it is used to detect cancer, determine the stage of disease, and monitor treatment response. The scan can identify primary tumors, detect metastases (cancer spread), and help determine if a lesion is cancerous or benign. This information is crucial for treatment planning and assessing whether therapy is working effectively. FDG PET can often detect disease earlier than other imaging methods.

Cardiac Applications

In cardiology, FDG PET is used to assess myocardial viability—determining whether heart tissue has been permanently damaged or whether it might recover function. This is particularly important for patients with heart disease who are considering revascularization procedures. The scan helps cardiologists decide whether procedures such as angioplasty or bypass surgery are likely to improve heart function.

Neurological and Brain Imaging

FDG PET is instrumental in diagnosing and monitoring neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and other forms of dementia. The scan reveals patterns of brain glucose metabolism that are characteristic of different neurological conditions. This information helps neurologists make accurate diagnoses and monitor disease progression over time.